Panel Discussion: From Chain of Custody to Chain of Usability: Making Every Biospecimen Decision-Ready

2:45 pm - Monday 16th November 2026

  • Defining “chain of usability” as the next evolution of chain of custody: Connecting sample integrity and provenance with the clinical, molecular and consent context needed to determine whether a sample is truly usable
  • As science gets more precise, sample intelligence has to keep up: Teams should know whether the right sample exists, fits the phenotype/genotype, and is permitted for use before it is retrieved or consumed
  • Moving from storage to research optionality: use connected sample, clinical and consent data to make smarter decisions about reuse, re-consent, retention and disposition as research priorities evolve

Speakers:

Founder & Chair
Biospecimen Industry Collaboration
Executive Director & Head of Precision Medicine, Laboratory Operations & Companion Diagnostics
Regeneron Pharmaceuticals
President - Strategic Endeavors
Astoriom
Chief Product Officer & Co-Founder
Embleema